BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 199 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $866,040 | +8.3% | 122,322 | +7.7% | 0.01% | +16.7% |
| Q2 2023 | $799,435 | -25.4% | 113,556 | -11.7% | 0.01% | -33.3% |
| Q1 2023 | $1,072,232 | -32.5% | 128,565 | -7.1% | 0.01% | -35.7% |
| Q4 2022 | $1,587,959 | +20.0% | 138,324 | +31.7% | 0.01% | +16.7% |
| Q3 2022 | $1,323,000 | -3.6% | 104,999 | -19.1% | 0.01% | +9.1% |
| Q2 2022 | $1,373,000 | -24.7% | 129,723 | +15.8% | 0.01% | 0.0% |
| Q1 2022 | $1,823,000 | +5.3% | 112,030 | -10.4% | 0.01% | +22.2% |
| Q4 2021 | $1,732,000 | +788.2% | 125,095 | +822.3% | 0.01% | +800.0% |
| Q3 2021 | $195,000 | -93.9% | 13,564 | -94.9% | 0.00% | -87.5% |
| Q4 2014 | $3,222,000 | +44.0% | 264,963 | +15.8% | 0.01% | +60.0% |
| Q3 2014 | $2,237,000 | +559.9% | 228,740 | +760.2% | 0.01% | +400.0% |
| Q2 2014 | $339,000 | +34.0% | 26,591 | +11.2% | 0.00% | 0.0% |
| Q1 2014 | $253,000 | +88.8% | 23,919 | +35.8% | 0.00% | – |
| Q4 2013 | $134,000 | +10.7% | 17,610 | +6.3% | 0.00% | – |
| Q3 2013 | $121,000 | +290.3% | 16,565 | -17.3% | 0.00% | – |
| Q2 2013 | $31,000 | – | 20,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |